BIOCON Q2 Result

BIOCON

• CONS NET PROFIT at ₹84.5 CR vs 16 CR loss (YOY), up 169% (QOQ) • REVENUE up 20% at ₹4,295 CR (YOY), up 9% (QOQ) • EBITDA up 22% at ₹835.2 CR (YOY), up 9% (QOQ) • MARGINS 19.09% vs 19.43% (YOY), 19.45% vs 19.43% (QOQ)